Population pharmacokinetics of remifentanil in patients undergoing orthotopic liver transplantation

Chinese Medical Journal

Volumn 122, Issue 9, 2009, Pages 1032-1038

  Zhang, Li Ping ^a   Yang, Lu ^a   Bi, Shan Shan ^b   Lu, Wei ^b   Zhang, Xian Hua ^a   Zhai, Suo Di ^a   Duan, Li Ping ^a  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Anesthesia; Liver transplantation; Pharmacokinetics; Remifentanil

Indexed keywords

FENTANYL; LORATADINE; MIDAZOLAM; PROPOFOL; REMIFENTANIL; VECURONIUM;

ADULT; ARTERIAL BLOOD; ARTICLE; BLOOD SAMPLING; BODY WEIGHT; CLINICAL ARTICLE; COMPARTMENT MODEL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIVER TRANSPLANTATION; MALE; POPULATION RESEARCH;

ADULT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PIPERIDINES; TANDEM MASS SPECTROMETRY;

EID: 68149150926     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2009.09.006     Document Type: Article

References (21)

1. Egan TD, Lemmens HJ, Fiset P, Hermann DJ, Muir KT, Stanski DR, et al. The pharmacokinetics of the new short-acting opioid remifentanil (GI87084B) in healthy adult male volunteers. Anesthesiology 1993; 79: 881-982.
2. Michelsen LG, Hcg CC Jr. The pharmacokinetics of Remifentanil. J Clin Anesthesia 1996; 8: 679-682.
3. Zhang XH, Zhang C, Zhang LP, Zhai SD. Determination of the concentration of remifentanil in blood by HPLC/MS/MS and its pharmacokinetic characteristics. Chin J New Drug 2006; 15: 137-141.
4. Wei SL, Zhang Q. Biopharmaceutics and pharmacokinetics. 2nd ed. Beijing: Peking University Medical Press; 1990: 238-270.
5. Bjorksten AR, Chan C, Crankshaw DP. Determination of remifentanil in human blood by capillary gas chromatography with nitrogen-selective detection. J Chromatogr B 2002; 775: 97-101.
6. Bender J, Elshout J, Selinger K, Broeders G, Dankers J, van der Heiden C. Determination of remifentanil in human heparinised whole blood by tandem mass spectrometry with short-column separation. J Pharm Biomed Anal 1999; 21: 559-567.
7. Grosse CM, Davis IM, Arrendale RF, Jersey J, Amin J. Determination of remifentanil in human blood by liquid-liquid extraction and capillary GC-HRMS-SIM using a deuterated internal standard. J Pharm Biomed Anal 1994; 12: 195-203.
8. Hermann DJ, Egan TD, Muir KT. Influence of arteriovenous sampling on remifentanil pharmacokinetics and pharmacodynamics. Clin Pharmacol Ther 1999; 65: 511-518.
9. Su CY, Han GZ. Clinical Pharmacokinetics. Beijing: Science Press; 2003: 132-134.
10. Ette EI. Stability and performance of a population pharmacokinetic model. J Clin Pharmacol 1997: 37: 486-495.
11. Drover DR, Lemmens HJ. Population pharmacodynamics and pharmacokinetics of remifentanil as a supplement to nitrous oxide anesthesia for elective abdominal surgery. Anesthesiology 1998; 89: 869-877.
12. Egan TD, Huizinga B, Gupta SK, Jaarsma RL, Sperry RJ, Yee JB, et al. Remifentanil pharmacokinetics in obese versus lean patients. Anesthesiology 1998; 89: 562-573.
13. Egan TD, Kern SE, Muir KT, White J. Remifentanil by bolus injection: a safety, pharmacokinetic, pharmacodynamic, and age effect investigation in human volunteers. Br J Anaesth 2004; 92: 335-343.
14. Bouillon T, Bruhn J, Radu-Radulescu L, Bertaccini E, Park S, Shafer S. Non-steady state analysis of the pharmacokinetic interaction between propofol and remifentanil. Anesthesiology 2002; 97: 1350-1362.
15. Russell D, Royston D, Rees PH, Gupta SK, Kenny GN. Effect of temperature and cardiopulmonary bypass on the pharmacokinetics of remifentanil. Br J Anesth 1997; 79: 456-459.
16. Michelsen LG, Holford NH, Lu W, Hoke JF, Huq CC, Bailey JM. The pharmacokinetics of remifentanil in patients undergoing coronary artery bypasses grafting with cardiopulmonary bypass. Anesth Analg 2001; 93: 1100-1105.
17. Minto CF, Schnider TW, Egan TD, Younqs E, Lemmens HJ, Gambus PL, et al. Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development. Anesthesilogy 1997; 86: 10-23.
18. Westmoreland CL, Hoke JF, Sebel PS, Huq CC Jr, Muir KT. Pharmacokinetics of remifentanil (GI87084B) and its major metabolite (GI90291) in patients undergoing elective inpatient surgery. Anesthesiology 1993; 79: 893-903.
19. Egan TD, Minto CF, Hermann DJ, Barr J, Muir KT, Shafer SL. Remifentanil versus alfentanil: comparative pharmacokinetics and pharmacodynamics in healthy adult male volunteers. Anesthesiology 1996; 84: 821-833.
20. Dershwitz M, Hoke JF, Rosow CE, Michalowski P, Connors PM, Muir KT, et al. Pharmacokinetics and pharmacodynamics of remifentanil in volunteer subjects with severe liver disease. Anesthesiology 1996; 84: 812-820.
21. Navapurkar VU, Archer S, Gupta SK, Muir KT, Frazer N, Park GR. Metabolism of remifentanil during liver transplantation. Br J Anaesth 1998; 81: 881-886.